Dynamics of Gut Microbiota Recovery after Antibiotic Exposure in Young and Old Mice (A Pilot Study)

From BugSigDB
Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Laubitz D, Typpo K, Midura-Kiela M, Brown C, Barberán A, Ghishan FK, Kiela PR
Journal
Microorganisms
Year
2021
Keywords:
16S, aging, antibiotics, bacteria, ciprofloxacin, metronidazole
Antibiotics have improved survival from previously deadly infectious diseases. Antibiotics alter the microbial composition of the gut microbiota, and these changes are associated with diminished innate immunity and decline in cognitive function in older adults. The composition of the human microbiota changes with age over the human lifespan. In this pilot study, we sought to identify if age is associated with differential recovery of the microbiota after antibiotic exposure. Using 16S rRNA gene sequencing, we compared recovery of the gut microbiota after the 10-day broad-spectrum antibiotic treatment in wild-type C57BL/six young and older mice. Immediately after antibiotic cessation, as expected, the number of ASVs, representing taxonomic richness, in both young and older mice significantly declined from the baseline. Mice were followed up to 6 months after cessation of the single 10-day antibiotic regimen. The Bray-Curtis index recovered within 20 days after antibiotic cessation in young mice, whereas in older mice the microbiota did not fully recover during the 6-months of follow-up. Bifidobacterium, Dubosiella, Lachnospiraceae_NK4A136_group became dominant in older mice, whereas in young mice, the bacteria were more evenly distributed, with only one dominant genus of Anaeroplasma. From 45 genera that became extinct after antibiotic treatment in young mice, 31 (68.9%) did not recover by the end of the study. In older mice, from 36 extinct genera, 27 (75%) did not recover. The majority of the genera that became extinct and never recovered belonged to Firmicutes phylum and Clostridiales family. In our study, age was a factor associated with the long-term recovery of the gut microbiota after the 10-day antibiotic treatment.

Experiment 1


Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/27

Curator: Gina

Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Gina, Peace Sandy

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Mus musculus
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Antimicrobial agent antibiotic,antibiotics,Antibiotika,Antibiotikum,antibiotique,antimicrobial,antimicrobial agents,microbicide,microbicides,Antimicrobial agent,antimicrobial agent
Group 0 name Corresponds to the control (unexposed) group for case-control studies
7 week old (young) mice before antibiotic treatment
Group 1 name Corresponds to the case (exposed) group for case-control studies
7 week old (young) mice 10 days after antibiotic treatments
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
7-week old mice (young mice) administered treated with broad-spectrum antibiotics metronidazole (500 mg/L) and ciprofloxacin (200 mg/L) for 10 days.
Group 0 sample size Number of subjects in the control (unexposed) group
5
Group 1 sample size Number of subjects in the case (exposed) group
5
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
Mice were not previously given antibiotics before the study

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/27

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between young mice after 10 days of antibiotic treatment

Abundance in Group 1: increased abundance in 7 week old (young) mice 10 days after antibiotic treatments

NCBI Quality ControlLinks
Enterococcaceae
Lactobacillales
Enterococcus

Revision editor(s): Gina

Signature 2

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/28

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between young after 10 days of Abx treatment

Abundance in Group 1: decreased abundance in 7 week old (young) mice 10 days after antibiotic treatments

NCBI Quality ControlLinks
Candidatus Stoquefichus
Clostridiales Family XIII bacterium
Erysipelotrichaceae
Erysipelotrichales
Faecalibaculum
Peptostreptococcaceae
Romboutsia
Clostridiales bacterium

Revision editor(s): Gina

Experiment 2


Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Gina, Victoria

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
7 week old (young) mice 6 months after antibiotic treatments

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
decreased

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between young after 6 months of recovery

Abundance in Group 1: increased abundance in 7 week old (young) mice 6 months after antibiotic treatments

NCBI Quality ControlLinks
Romboutsia
Peptostreptococcaceae
Dubosiella

Revision editor(s): Gina

Signature 2

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between young after 6 months of recovery (lower panels)

Abundance in Group 1: decreased abundance in 7 week old (young) mice 6 months after antibiotic treatments

NCBI Quality ControlLinks
Clostridiales Family XIII bacterium
Candidatus Stoquefichus

Revision editor(s): Gina

Experiment 3


Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Gina, Victoria

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
40 week old (old) mice before antibiotic treatment
Group 1 name Corresponds to the case (exposed) group for case-control studies
40 week old (old) mice 10 days after antibiotic treatments
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
40-week old mice (old) administered treated with broad-spectrum antibiotics metronidazole (500 mg/L) and ciprofloxacin (200 mg/L) for 10 days.

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between older mice (right panels) after 10 days of Abx treatment

Abundance in Group 1: increased abundance in 40 week old (old) mice 10 days after antibiotic treatments

NCBI Quality ControlLinks
Bacteroidales

Revision editor(s): Gina

Signature 2

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between older mice (right panels) after 10 days of Abx treatment.

Abundance in Group 1: decreased abundance in 40 week old (old) mice 10 days after antibiotic treatments

NCBI Quality ControlLinks
Romboutsia
Peptostreptococcaceae
Faecalibaculum
Erysipelotrichaceae
Erysipelotrichales

Revision editor(s): Gina

Experiment 4


Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Gina, Victoria

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
40 week old (old) mice 6 months after antibiotic treatments

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between older mice (right panels) after 6 months of recovery (lower panels).

Abundance in Group 1: decreased abundance in 40 week old (old) mice 6 months after antibiotic treatments

NCBI Quality ControlLinks
Bacteroidales
Faecalibaculum
Muribaculaceae
Muribaculum
Peptostreptococcaceae
Romboutsia
Clostridiales bacterium

Revision editor(s): Gina

Signature 2

Reviewed Marked as Reviewed by Claregrieve1 on 2022/11/27

Curated date: 2021/09/29

Curator: Gina

Revision editor(s): Gina

Source: Figure 5

Description: Linear discriminant analysis (LDA) effect size (LEfSe) of differentially abundant bacterial taxa between older mice after 6 months of recovery

Abundance in Group 1: increased abundance in 40 week old (old) mice 6 months after antibiotic treatments

NCBI Quality ControlLinks
Dubosiella
Erysipelotrichaceae
Erysipelotrichales

Revision editor(s): Gina